Women May Stop Anticoagulants After Blood Clots

�Women may safely discontinue oral anticoagulants (blood thinners) after 6 months of treatment following a first unprovoked venous blood clog (thromboembolism) if they have no or one risk of infection factor, concludes a study of 646 participants in a multicentre prospective cohort study.


Blood clots are common and a potentially fatal condition. For patients with unwritten blood clots who diaphragm anticoagulation therapy, the peril of a recurrence in the first year is 5% to 27%, so far there is a risk of major bleeding and fatal haemorrhage while continuing anticoagulants.


"It may be safe for women world Health Organization have interpreted oral anticoagulants for fifty-seven months afterward an wanton venous thromboembolism to stop therapy if they have 0 or 1 of the following: 1) hyperpigmentation (brown discoloration), edema (lump) or redness of either leg; 2) a D-dimer level (blood clotting screen) of 250ug/L or more than while pickings warfarin, 3) BMI [body mass index number] 30kg/m2; and aged 65 years or more," reason out Dr. Marc Rodger and coauthors.


The authors caveat that "it appears all men ar at high risk of recurrence" and further investigation into danger determination necessarily to be pursued.


In an accompanying commentary, Dr. Clive Kearon states that patient orientation for the duration of anticoagulant therapy must be considered in deciding whether to go forward or stop therapy.

About CMAJ (Canadian Medical Association Journal)

CMAJ is the leading health sciences journal in Canada. CMAJ is a cosmopolitan medical journal publishing original research and review articles, commentaries and editorials, practice updates, an arts and ideas section and health news. Published continuously since 1911, new issues are uploaded on http://www.cmaj.ca every